Showing results (11-20 of 53) with videos related to
Sort By:
Pageof 6
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|June 17, 2008
Primary non-Hodgkin's lymphoma of the bladder: report of two cases and review of the literatureD Pectasides, I Iacovidou, A Psyrri, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 4, 2014
RAS/PI3K crosstalk and cetuximab resistance in head and neck squamous cell carcinomaT Rampias, A Giagini, S Siolos, et al.Bone Marrow Transplantation|August 5, 2000
The feasibility of high-dose chemotherapy in breast cancer patients with impaired left ventricular functionM Rose, F A Lee, A Gollerkeri, et al.ESMO Open|March 13, 2021
The DNA damage response network in the treatment of head and neck squamous cell carcinomaA Psyrri, M Gkotzamanidou, G Papaxoinis, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 8, 2008
Human tissue kallikrein 7, a novel biomarker for advanced ovarian carcinoma using a novel in situ quantitative method of protein expressionA Psyrri, P Kountourakis, A Scorilas, et al.Journal of Chemotherapy (Florence, Italy)|August 5, 2008
Primary ovarian lymphoma: report of two cases and review of the literatureD Pectasides, I Iacovidou, A Psyrri, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 1, 2014
Impact of tumor HPV status on outcome in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck receiving chemotherapy with or without cetuximab: retrospective analysis of the phase III EXTREME trialJ B Vermorken, A Psyrri, R Mesía, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 16, 2007
Analysis of p53 protein expression levels on ovarian cancer tissue microarray using automated quantitative analysis elucidates prognostic patient subsetsA Psyrri, P Kountourakis, Z Yu, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 10, 2004
Prognostic significance of p16 protein levels in oropharyngeal squamous cell cancerPaul M Weinberger, Z Yu, B G Haffty, et al.Gynecologic Oncology|April 22, 2010
Carboplatin/gemcitabine alternating with carboplatin/pegylated liposomal doxorubicin and carboplatin/cyclophosphamide in platinum-refractory/resistant paclitaxel - pretreated ovarian carcinomaD Pectasides, E Pectasides, G Papaxoinis, et al.Pageof 6